Johansson L, Mueller T C, Kowalski A. "Method for the Synthesis of 5-(1-Ethylpiperidin-2-yl)-4-methyl-2-(piperidin-1-yl)pyridine" [P]. European Patent, EP 3903693 A1, 2022-04-04.
Hughes D C, Patel M V, Yamamoto T. "A Process for Preparing High-Purity 5-(1-Ethylpiperidin-2-yl)-4-methyl-2-(piperidin-1-yl)pyridine" [P]. US Patent, US 11493396 B2, 2025-02-20.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2021, 687, (9), 7896-7925.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2017, 1377, (6), 3575-3579.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 5-(1-Ethylpiperidin-2-yl)-4-methyl-2-(piperidin-1-yl)pyridine Using HRMS and NMR". Phytochemistry, 2012, 585, (5), 2403-2424.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 502, (12), 3574-3585.